These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26524351)

  • 1. Hyperinsulinemia in individuals with obesity: Role of insulin clearance.
    Kim MK; Reaven GM; Chen YD; Kim E; Kim SH
    Obesity (Silver Spring); 2015 Dec; 23(12):2430-4. PubMed ID: 26524351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the relationship between obesity and hyperinsulinemia: Role of insulin secretion and insulin clearance.
    Kim MK; Reaven GM; Kim SH
    Obesity (Silver Spring); 2017 Feb; 25(2):378-383. PubMed ID: 28000428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting to insulin resistance in obesity: role of insulin secretion and clearance.
    Jung SH; Jung CH; Reaven GM; Kim SH
    Diabetologia; 2018 Mar; 61(3):681-687. PubMed ID: 29196782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals.
    McLaughlin T; Allison G; Abbasi F; Lamendola C; Reaven G
    Metabolism; 2004 Apr; 53(4):495-9. PubMed ID: 15045698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls.
    McLaughlin T; Abbasi F; Lamendola C; Frayo RS; Cummings DE
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1630-5. PubMed ID: 15070922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.
    Yeni-Komshian H; Carantoni M; Abbasi F; Reaven GM
    Diabetes Care; 2000 Feb; 23(2):171-5. PubMed ID: 10868826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between obesity and insulin resistance in the association with C-reactive protein.
    McLaughlin T; Abbasi F; Lamendola C; Liang L; Reaven G; Schaaf P; Reaven P
    Circulation; 2002 Dec; 106(23):2908-12. PubMed ID: 12460870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
    McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
    Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, insulin response, and obesity as indicators of metabolic risk.
    Ferrannini E; Balkau B; Coppack SW; Dekker JM; Mari A; Nolan J; Walker M; Natali A; Beck-Nielsen H;
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2885-92. PubMed ID: 17504904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers.
    Abbasi F; McLaughlin T; Lamendola C; Reaven GM
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1251-4. PubMed ID: 10720071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of body mass index on diabetogenesis factors at a fixed fasting plasma glucose level.
    Lin JD; Hsu CH; Wu CZ; Hsieh AT; Hsieh CH; Liang YJ; Chen YL; Pei D; Chang JB
    PLoS One; 2018; 13(1):e0189115. PubMed ID: 29377927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR).
    Abbasi F; Okeke Q; Reaven GM
    Acta Diabetol; 2014 Apr; 51(2):193-7. PubMed ID: 23420066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characteristics and risk factors for insulin resistance at different levels of obesity.
    Guerrero-Romero F; Aradillas-García C; Simental-Mendía LE; Torres-Rodríguez ML; Mendoza Ede L; Rosales-Cervantes J; Rodríguez-Ramírez G; Rodríguez-Moran M
    Pediatrics; 2013 Apr; 131(4):e1211-7. PubMed ID: 23478864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hyperinsulinemia reduces plasma leptin levels in insulin-sensitive Japanese men.
    Masuo K; Katsuya T; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):235-43. PubMed ID: 15752952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.
    Gupta AK; Jain SK
    J Assoc Physicians India; 2004 Jul; 52():549-53. PubMed ID: 15645980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
    Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women.
    Abbasi F; Lamendola C; McLaughlin T; Hayden J; Reaven GM; Reaven PD
    Metabolism; 2004 Mar; 53(3):280-3. PubMed ID: 15015137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.